Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes.
Vakkilainen
Juha
J
Steiner
George
G
Ansquer
Jean-Claude
JC
Perttunen-Nio
Hëlina
H
Taskinen
Marja-Riitta
MR
D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D003925:Diabetic Angiopathies / Q000517:prevention & control; D011345:Fenofibrate / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008077:Lipoproteins, LDL / Q000097:blood*; D010919:Placebos; D014280:Triglycerides / Q000097:blood*
D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL; D010919:Placebos; D014280:Triglycerides; D011345:Fenofibrate